microRNA106a modulates cisplatin sensitivity by targeting PDCD4 in human ovarian cancer cells

By        

Oncology Letters, Vol. 7, Iss. 1, 2014-01 ,pp. : 183-188

Spandidos Publications

Access to resources Recommend Favorite

Tolerance to endoplasmic reticulum stress mediates cisplatin resistance in human ovarian cancer cells by maintaining endoplasmic reticulum and mitochondrial homeostasis

By                      

Oncology Reports, Vol. 34, Iss. 6, 2015-01 ,pp. : 3051-3060

Spandidos Publications

Access to resources Recommend Favorite

Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells

By Marverti Gaetano   Ligabue Alessio   Lombardi Paolo   Ferrari Stefania   Monti Maria Giuseppina   Frassineti Chiara   Costi Maria Paola  

International Journal of Oncology, Vol. 43, Iss. 4, 2013-10 ,pp. : 1269-1280

Spandidos Publications

Access to resources Recommend Favorite

Apoptosis-inducing effect of the DR5 monoclonal antibody, D-6, alone or in combination with cisplatin, on A2780 ovarian cancer cells

By          

Molecular Medicine Reports, Vol. 6, Iss. 2, 2012-01 ,pp. : 316-320

Spandidos Publications

Access to resources Recommend Favorite

Expression of oncogenic HMGN5 increases the sensitivity of prostate cancer cells to gemcitabine

By  

Oncology Reports, Vol. 33, Iss. 3, 2015-01 ,pp. : 1519-1525

Spandidos Publications

Access to resources Recommend Favorite